Pooling the datasets to calculate the composite SMD, KCNK1 mRNA was significantly increased in 1264 BC samples compared to 222 control samples (SMD = 0.58, 95% CI [0.05; 1.11]; Fig. 2B). The gene discussed is KCNK1; the disease is breast cancer.